PapersFlow Research Brief

Global Public Health Policies and Epidemiology
Research Guide

What is Global Public Health Policies and Epidemiology?

Global Public Health Policies and Epidemiology is the study of how population-level disease patterns and risk factors are measured and modeled, and how that evidence is translated into policies and programs to prevent illness, reduce mortality, and improve health equity across countries and regions.

Global Public Health Policies and Epidemiology spans descriptive measurement (e.g., prevalence, mortality, disability) and analytic attribution of health loss to modifiable risks, often using standardized comparative frameworks across places and time. "Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019" (2020) exemplifies this approach by compiling comparable estimates across 204 countries and territories over 1990–2019. The provided literature set contains 100,624 works, indicating a large research base for linking epidemiologic evidence to policy decisions, while 5-year growth is listed as N/A.

100.6K
Papers
N/A
5yr Growth
999.6K
Total Citations

Research Sub-Topics

Why It Matters

Policy choices about prevention, screening, treatment access, and health-system priorities depend on credible estimates of what conditions and risks cause the most health loss, and how those burdens vary by place and over time. Large comparative assessments such as Vos et al. (2020) in "Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019" and Lozano et al. (2012) in "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010" provide a common quantitative language that ministries of health and global funders use to prioritize interventions. Risk-focused syntheses like Lim et al. (2012) in "A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010" support concrete policy levers—such as tobacco control, dietary regulation, and environmental health standards—by attributing burden to specific exposures. Condition-specific epidemiology also drives program design: Wild et al. (2004) in "Global Prevalence of Diabetes" estimated prevalence and counts for 2000 and 2030, while Sun et al. (2021) in "IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045" extends prevalence estimation and projection to 2045, informing long-horizon planning for medicines, workforce, and financing. Similarly, WHO guidance in "Obesity: preventing and managing the global epidemic. Report of a WHO consultation." (2000) connects epidemiologic trends in overweight/obesity to policy-relevant prevention and management strategies, and Roth et al. (2020) in "Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019" situates cardiovascular policy within long-run global burden accounting.

Reading Guide

Where to Start

Start with Mathers and Lončar (2006), "Projections of Global Mortality and Burden of Disease from 2002 to 2030," because it introduces how epidemiologic evidence is converted into policy-relevant scenarios and planning horizons without requiring deep familiarity with the full GBD machinery.

Key Papers Explained

A coherent path through the core evidence base begins with cause-of-death accounting in Lozano et al. (2012), "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010," then adds risk attribution via Lim et al. (2012), "A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010." Vos et al. (2020), "Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019," extends the same comparative logic to a broader outcome set and longer time series, while Roth et al. (2020), "Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019," shows how a major disease group can be analyzed in depth within the global burden framework. For policy translation in specific domains, pair these with WHO (2000), "Obesity: preventing and managing the global epidemic. Report of a WHO consultation.," and with diabetes-focused estimation and projection in Wild et al. (2004), "Global Prevalence of Diabetes," and Sun et al. (2021), "IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045."

Paper Timeline

100%
graph LR P0["Obesity: preventing and managing...
2000 · 13.2K cites"] P1["Obesity : Preventing and managin...
2000 · 13.0K cites"] P2["Global Prevalence of Diabetes
2004 · 15.2K cites"] P3["Home visits: a strategy to impro...
2008 · 22.5K cites"] P4["Global and regional mortality fr...
2012 · 14.1K cites"] P5["A comparative risk assessment of...
2012 · 11.9K cites"] P6["Global burden of 369 diseases an...
2020 · 18.0K cites"] P0 --> P1 P1 --> P2 P2 --> P3 P3 --> P4 P4 --> P5 P5 --> P6 style P3 fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan

Most-cited paper highlighted in red. Papers ordered chronologically.

Advanced Directions

Advanced work in this area often focuses on improving comparability across places and time while maintaining policy interpretability: integrating risk-attribution results (Lim et al. (2012)) with disease-specific deep dives (Roth et al. (2020)) and ensuring consistent accounting in all-cause updates (Vos et al. (2020)). A second frontier is decision support under uncertainty, extending the scenario logic of Mathers and Lončar (2006) to policy portfolios and implementation constraints, while retaining transparent assumptions that policymakers can audit.

Papers at a Glance

In the News

A Global Health Strategy for 2025–2028

May 2025 who.int Director-General Office (DGO)

The Fourteenth General Programme of Work (GPW14), adopted by Member States at the Seventy-seventh World Health Assembly represents an ambitious new global health strategy for 2025––2028. It builds ...

A Global Health Strategy for 2025–2028: executive summary

Feb 2025 who.int

The Fourteenth General Programme of Work (GPW14), adopted by Member States at the Seventy-seventh World Health Assembly represents an ambitious new global health strategy for 2025––2028. It builds ...

Strategic plan for coronavirus disease threat management: advancing integration, sustainability, and equity, 2025–2030

Dec 2025 who.int

# Strategic plan for coronavirus disease threat management: advancing integration, sustainability, and equity, 2025–2030 2 December 2025 ||Global strategy

WHO global framework to define and guide studies into the origins of emerging and re-emerging pathogens with epidemic and pandemic potential

Feb 2025 who.int Scientific Advisory Group on the Origins of Novel Pathogens (SAGO)

# WHO global framework to define and guide studies into the origins of emerging and re-emerging pathogens with epidemic and pandemic potential Developed by the Scientific Advisory Group for the Ori...

A global health strategy for 2025-2028: advancing equity and resilience in a turbulent world: fourteenth General Programme of Work: executive summary

Feb 2025 iris.who.int World Health Organization

World Health Organization. (‎2025)‎. A global health strategy for 2025-2028: advancing equity and resilience in a turbulent world: fourteenth General Programme of Work: executive summary. World Hea...

Code & Tools

Recent Preprints

Latest Developments

Recent developments in global public health policies and epidemiology research as of February 2026 include a focus on maintaining high vaccine coverage, addressing health system fragmentation due to conflict and displacement, and implementing integrated frameworks for drug resistance in HIV, hepatitis B and C, and STIs (The South First, WHO). Additionally, the U.S. has approved a major global health funding package for 2026, with significant investments in HIV/AIDS programs, and the US has exited the WHO, marking a significant shift in international health collaboration (George W. Bush Center, The Conversation). Key issues include rising conflict and displacement impacting health systems, antimicrobial resistance, and emerging health threats (Project HOPE, Impact Funding).

Frequently Asked Questions

What does "Global Public Health Policies and Epidemiology" include in practice?

Global Public Health Policies and Epidemiology includes measuring population health outcomes (e.g., prevalence and cause-specific mortality), attributing burden to risk factors, and using those results to set priorities for prevention and health services. Vos et al. (2020) in "Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019" illustrates how standardized estimates across 204 countries can support comparable policy planning.

How do Global Burden of Disease studies support policy decisions?

Global Burden of Disease studies support policy by producing comparable estimates of diseases, injuries, and causes of death across locations and time, enabling priority-setting and tracking progress. Lozano et al. (2012) in "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010" and Vos et al. (2020) in the 2019 GBD paper provide multi-cause, multi-country baselines that can be aligned with national plans and donor portfolios.

How is the burden attributable to risk factors estimated at global scale?

Burden attributable to risk factors is estimated by combining exposure distributions, relative risks, and counterfactual scenarios to quantify how much disease and injury could be avoided if exposures were reduced. Lim et al. (2012) in "A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010" operationalized this logic across 67 risks and 21 regions over 1990–2010.

Which papers are most useful for informing global diabetes policy?

Wild et al. (2004) in "Global Prevalence of Diabetes" is useful for understanding how prevalence estimation and extrapolation were used to produce global counts and projections for 2000 and 2030. Sun et al. (2021) in "IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045" is useful for more recent prevalence estimates and longer-range projections to 2045 that can be translated into planning targets for medicines, screening, and chronic-care capacity.

Which sources anchor obesity policy guidance in global public health?

"Obesity: preventing and managing the global epidemic. Report of a WHO consultation." (2000) is a central policy-oriented synthesis linking obesity epidemiology to prevention and management recommendations. Akram et al. (2000) in "Obesity : Preventing and managing the global epidemic" provides an additional citable version of the same policy-relevant framing for obesity as a global public health problem.

How are future health needs projected for policy planning?

Future health needs are projected by combining current burden patterns with explicit assumptions about demographic and epidemiologic trends to generate alternative scenarios. Mathers and Lončar (2006) in "Projections of Global Mortality and Burden of Disease from 2002 to 2030" presented projections intended to clarify the policy implications of observed trends while acknowledging uncertainty ranges.

Open Research Questions

  • ? How can comparative burden frameworks like Vos et al. (2020) be translated into decision rules that explicitly trade off mortality reduction, disability reduction, and equity across countries and subnational populations?
  • ? Which methodological choices in comparative risk assessment (as in Lim et al. (2012)) most strongly change policy priorities when multiple correlated risks are targeted simultaneously?
  • ? How should projection models (as in Mathers and Lončar (2006)) incorporate structural breaks—such as rapid policy adoption or health-system shocks—without overstating forecast certainty?
  • ? How can disease-specific global estimates (e.g., Wild et al. (2004); Sun et al. (2021)) be reconciled with all-cause, multi-disease accounting (e.g., Vos et al. (2020)) to avoid double-counting and inconsistent denominators in policy planning?
  • ? Which policy packages best reduce long-run cardiovascular burden when evaluated against global risk-factor trends summarized by Roth et al. (2020) and Lim et al. (2012)?

Research Global Public Health Policies and Epidemiology with AI

PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:

Start Researching Global Public Health Policies and Epidemiology with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.